Suzanne E McKenna Selected Research

COG1410

12/2010	COG1410, an apolipoprotein E-based peptide, improves cognitive performance and reduces cortical loss following moderate fluid percussion injury in the rat.
1/2009	COG1410 improves cognitive performance and reduces cortical neuronal loss in the traumatically injured brain.
7/2007	COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury.
7/2007	The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suzanne E McKenna Research Topics

Disease

3	Brain Contusion 12/2010 - 07/2007
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2009 - 07/2007
1	Cognitive Dysfunction 12/2010
1	Retrograde Amnesia 12/2010
1	Craniocerebral Trauma (Head Injury) 07/2007
1	Brain Injuries (Brain Injury) 07/2007
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2006
1	Autoimmune Diseases (Autoimmune Disease) 09/2006
1	Multiple Sclerosis 09/2006

Drug/Important Bio-Agent (IBA)

5	ApolipoproteinsIBA 12/2010 - 09/2006
5	Peptides (Polypeptides)IBA 12/2010 - 09/2006
5	Apolipoproteins E (ApoE)IBA 12/2010 - 09/2006
4	COG1410IBA 12/2010 - 07/2007
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2009 - 07/2007
1	Proteins (Proteins, Gene)FDA Link 09/2006
1	PeptidomimeticsIBA 09/2006
1	CytokinesIBA 09/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2006

Therapy/Procedure

1	Therapeutics 07/2007